Basic Information
| LncRNA/CircRNA Name | RP11-181G12.2 |
| Synonyms | NA |
| Region | GRCh38_1:2181794-2184389 |
| Ensemble | ENSG00000182873 |
| Refseq | NR_146290 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR, Western blot etc. |
| Sample | cell lines(SGC-7901, MGC-803, BGC-823 and AGS) |
| Expression Pattern | differential expressed |
| Function Description | LncRNA RP11-181G12.2 expression was negatively related to DCSIGN expression and the activation of the JAK2/STAT3 signaling pathway in GC cells |
| Pubmed ID | 31766099 |
| Year | 2019 |
| Title | DC-SIGN Mediates Gastric Cancer Progression by Regulating the JAK2/STAT3 Signaling Pathway and Affecting LncRNA RP11-181G12.2 Expression |
External Links
| Links for RP11-181G12.2 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |